Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Northwest-Bio-Appoint

More Like This

PR Newswire associated0

Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments

PR Newswire associated0

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property

PR Newswire associated0

Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma

PR Newswire associated0

Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.

PR Newswire associated0

Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed

PR Newswire associated0

Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application

PR Newswire associated0

Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification

PR Newswire associated0

Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman